Delve into dermatology diseases with new approaches from conventional to complementary care.
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
The largest integrative dermatology community.

Review case management skills in this case-based microlearning course featuring a patient with a history of severe atopic dermatitis experiencing a new onset eruption while on treatment.

Review case management skills in this case-based microlearning course featuring a patient with chronic severe atopic dermatitis and a new rash on the neck/face.

Review case management skills in this case-based microlearning course featuring a patient with chronic severe atopic dermatitis.

Review case management skills in this case-based microlearning course featuring a patient with chronic severe atopic dermatitis.

Review case management skills in this case-based microlearning course featuring a patient with atopic dermatitis.

Review case management skills in this case-based microlearning course featuring a patient with atopic dermatitis and sleep disturbances.

Review case management skills in this case-based microlearning course featuring a pediatric patient with atopic dermatitis experiencing social withdrawal and other signs of psychological impact.

Review case management skills in this case-based microlearning course featuring a patient with atopic dermatitis and sleep disturbances.



This session will include expert dermatologists who will consolidate the information from the previous modules to evaluate and discuss multiple cases of atopic dermatitis and their approaches to diagnosis and therapy.


This session will review the clinical presentation of AD and when to consider the use of systemic agents. The epidemiological associations as well as the associated physical and psychological co-morbidities of AD will be reviewed. The clinical evidence for topical and systemic JAK inhibition will also be discussed.

Dr. Peter Lio is a Clinical Assistant Professor of Dermatology and Pediatrics at the Northwestern University Feinberg School of Medicine. He received his medical degree from Harvard Medical School, completed his internship in Pediatrics at Boston Children's Hospital, and his Dermatology training at Harvard where he served as Chief Resident in Dermatology. Dr. Lio is the founding director of the Chicago Integrative Eczema Center and has spoken nationally and internationally about atopic dermatitis, as well as alternative medicine.

Dr. Song is the director of clinical research at Frontier Dermatology Partners. He is also a clinical instructor at the University of Washington and Silver Falls Dermatology. He specializes in inflammatory skin diseases, including psoriasis, atopic dermatitis, and hidradenitis suppurativa. Dr. Song is a regular contributor to the dermatology literature and speaks across the country as a key opinion leader.

Dr. Hawkes is a board-certified dermatologist and Investigator at the Oregon Medical Research Center in Portland, Oregon. He completed his medical school and residency at the University of Utah. During medical school, he completed a fellowship in translational immunology in the NIH-HHMI Research Scholars Program. He also received a Master’s Degree in Clinical Investigation from Rockefeller University, where he was Chief Clinical Scholar and Principal and sub-Investigator on multiple human research protocols in the Laboratory for Investigative Dermatology. He has held academic appointments in the Departments of Dermatology at the University of Utah, University of California-Davis, Icahn School of Medicine at Mount Sinai.
Dr. Hawkes is a current Councilor in the International Psoriasis Council and serves on the NPF Medical Board and Scientific Advisory Committee. He also serves as the official delegate of the AAD as a member of the international guidelines and workgroup committee for urticaria. His research has been funded by the NIH, NSF, NPF, and Dermatology Foundation, and he is the recipient of several teaching awards including NPF Outstanding Educator in Psoriatic Disease and Exceptional Teacher of the Year in the Department of Dermatology at Mount Sinai. His primary clinical and research interests include novel immune therapies for inflammatory conditions like psoriasis, atopic dermatitis, HS, alopecia areata, vitiligo, and urticaria.

Lacey Kruse, MD is an Associate Professor of Pediatrics and Dermatology at Northwestern University Feinberg School of Medicine. She has a special interest and dedication to medical education of medical students, residents, and fellows. She also serves as program director for the Pediatric Dermatology Fellowship at Ann & Robert H. Lurie Children’s Hospital of Chicago.
Dr. Kruse’s clinical and research interests include pediatric skin cancer, pigmented lesions in children, and pediatric atopic dermatitis. Her research focuses on the impact of pediatric atopic dermatitis on sleep and neurocognitive function.